Related Experiment Videos
The effects of 6-hydroxydopamine on vagal cardioaccelerator systems
The Journal of Pharmacology and Experimental Therapeutics
|October 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Functional correlates of central arterial geometric phenotypes.
Hypertension (Dallas, Tex. : 1979)·2001
Measurement variation of aortic pulse wave velocity in the elderly.
American journal of hypertension·2001
High-density lipoprotein cholesterol and vascular stiffness at baseline in the activity counseling trial.
The American journal of cardiology·2001
Cardiac synthesis, processing, and coronary release of enkephalin-related peptides.
American journal of physiology. Heart and circulatory physiology·2000
Shortening deactivation of cardiac muscle: physiological mechanisms and clinical implications.
Journal of investigative medicine : the official publication of the American Federation for Clinical Research·1999
Impact of Δ9-tetrahydrocannabinol and oxycodone coadministration on measures of antinociception, dependence, circadian activity, and reward in mice.
The Journal of pharmacology and experimental therapeutics·2026
Repurposing ribavirin for oncology: Integrating metabolism, signaling, and translational control.
The Journal of pharmacology and experimental therapeutics·2026
Circular RNAs regulate the progression of pulmonary hypertension through distinct roles and mechanisms.
The Journal of pharmacology and experimental therapeutics·2026
US postmarketed drug removals: Analysis of discontinued and withdrawn drugs.
The Journal of pharmacology and experimental therapeutics·2026
RRx-001 sensitizes triple-negative breast cancer cells to oxaliplatin through apoptosis, cell cycle arrest, and immune modulation.
The Journal of pharmacology and experimental therapeutics·2026
Dynamic mechanistic dominance in fentanyl and polysubstance overdose: Implications for next-generation reversal.
The Journal of pharmacology and experimental therapeutics·2026